BNGO
Bionano Genomics Inc
NASDAQ: BNGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.16
-2.52% today
Updated 2026-04-29
Market cap
$13.42M
P/E ratio
—
P/S ratio
0.47x
EPS (TTM)
$-4.85
Dividend yield
—
52W range
$1 – $6
Volume
0.3M
Bionano Genomics Inc (BNGO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-23.50M | $-20.82M | $-19.94M | $-29.53M | $-38.31M | $-71.93M | $-124.82M | $-125.18M | $-68.92M | $-16.34M |
| Capital expenditures | $1.35M | $1.02M | $331716.00 | $61056.00 | $4.66M | $1.46M | $3.30M | $1.69M | $103000.00 | $0.00 |
| Depreciation | $1.12M | $1.50M | $1.32M | $1.13M | $1.48M | $3.37M | $9.84M | $13.91M | $14.23M | — |
| Stock-based comp | $130643.00 | $382830.00 | $1.31M | $1.35M | $1.55M | $9.72M | $22.42M | $15.18M | $9.74M | $4.53M |
| Free cash flow | $-24.85M | $-21.84M | $-20.28M | $-29.59M | $-42.97M | $-73.39M | $-128.12M | $-126.87M | $-69.03M | $-16.34M |
| Investing cash flow | $-1.35M | $-1.02M | $-331716.00 | $-61056.00 | $-2.45M | $-278.06M | $82.77M | $24.16M | $73.84M | — |
| Financing cash flow | $25.43M | $17.61M | $35.78M | $30.38M | $61.90M | $336.11M | $23.01M | $113.81M | $-13.69M | — |
| Dividends paid | — | — | — | — | $2.00M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $15.50M | $788644.00 | $21.14M | $-13.88M | $-19.04M | — | — | — |